Kalmar Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Kalmar Investments’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-148,310	Closed	-$25.6M	–	166
2015 Q1	$25.6M	Sell	148,310 -199,535	-57%	-$29.3M	0.48%	78
2014 Q4	$40M	Buy	347,845 +1,295	+0.4%	+$157K	0.74%	57
2014 Q3	$54.1M	Sell	346,550 -139,785	-29%	-$20.3M	1.03%	31
2014 Q2	$60M	Buy	486,335 +7,295	+2%	+$806K	1.03%	31
2014 Q1	$49.6M	Sell	479,040 -210	-0%	-$21.5K	0.84%	44
2013 Q4	$43.1M	Buy	479,250 +5,530	+1%	+$441K	0.72%	55
2013 Q3	$31.7M	Sell	473,720 -1,530	-0.3%	-$105K	0.56%	72
2013 Q2	$31.4M	Buy	+475,250	New	+$27.2M	0.62%	68

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Kalmar Investments's SLXP Position: Q2 2015 in Review

Kalmar Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 148,310 shares — an estimated $25.6M sold.

Kalmar Investments first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $60M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Kalmar Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Kalmar Investments sold 148,310 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $25.6M.
Kalmar Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Kalmar Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $60M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Kalmar Investments's 13F filing for Q2 2015, filed 24 Jul 2015.